Diversity and inclusion in clinical trials [one-page primer]
People of color have been (and continue to be) particularly underrepresented in clinical research. Historically, the numbers of clinical trial participants from diverse populations have not reflected real-world populations. The lack of diversity in clinical trials can make it particularly challenging to get a complete picture of a drug’s safety and efficacy. That’s why it’s critical that the makeup of clinical trial participants reflects real-world populations, so that medications are tested for all who may need them.